男性膀胱出口梗阻药物治疗中抗胆碱能药物的使用趋势
该研究利用2006至2014年美国门诊医疗调查数据库,评估40岁以上接受膀胱出口梗阻药物治疗的男性中抗胆碱能药物的使用变化趋势。
要点
- 40岁以上接受膀胱出口梗阻药物治疗的男性中,抗胆碱能药物使用率为3.7%。
- 抗胆碱能药物使用随年龄增长而增加。
核心结论
- 在2006年至2014年间,接受膀胱出口梗阻药物治疗的男性中抗胆碱能药物使用无增加趋势,提示潜在治疗不足。
主要发现
- 总体抗胆碱能药物使用率为3.7%,且使用率随年龄增长而增加。
临床怎么用
- 临床医生应关注接受膀胱出口梗阻药物治疗的男性中抗胆碱能药物的潜在治疗不足,并考虑优化处方。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess changes over time in the use of antimuscarinics (AM) among visits in adult men treated with bladder outlet obstruction (BOO) medication therapy (ie, alpha blocker and 5-alpha reductase inhibitors). METHODS: We used the National Ambulatory Medicare Care Survey database (2006-2014) to identify men aged 40 or older, who initiated or continued on BOO medication therapy. Among these visits, we assessed the percentage of AM and evaluated trends of AM use across between 2006 and 2014 using multivariable logistic regression. RESULTS: Overall, there were 7561 patient visits in men aged 40 or older, who were treated with BOO medication therapy between 2006 and 2014 which equates to approximately 158 million visits in the United States after incorporating National Ambulatory Medicare Care Survey weights. Overall, AM was used in 3.7% of visits, among those who were treated with BOO medication therapy; use of AM increased with age. In the multivariable analysis, there was no increasing trend in the use of AM in 2006 relative to subsequent years through 2014 (P = .8104). CONCLUSION: Despite a previous study that showed an increasing trend in antimuscarinic use among patients coded for lower urinary tract symptoms or benign prostatic hyperplasia between 1993 and 2010, several recent randomized-controlled trials, and a recommendation in a clinical practice guideline in 2010, we found no increasing trend in antimuscarinic use among visits in men who were treated with BOO medication therapy in 2006 compared to subsequent years. This suggests the potential undertreatment of antimuscarinics and an area for improved prescribing.
引用
- Vouri SM, Strope SA, Olsen MA, et al. Antimuscarinic Use in Men Treated With Bladder Outlet Obstruction Medication Therapy. Urology. 2018. PMID: 30205105. doi:10.1016/j.urology.2018.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。